These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 2826368

  • 1. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
    Clarke SE, Lazarus CR, Maisey MN.
    Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
    [No Abstract] [Full Text] [Related]

  • 2. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J, Konishi J, Torizuka K, Makimoto K, Miyauchi A.
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract] [Full Text] [Related]

  • 3. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE, Connell JM, Elliot AT, Murray T, Reed NS.
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [Abstract] [Full Text] [Related]

  • 4. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN.
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [Abstract] [Full Text] [Related]

  • 5. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H, Endo K, Fujita T, Koizumi M, Konishi J, Maki A, Mori K, Ozawa K, Inoue G, Nakano Y.
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [Abstract] [Full Text] [Related]

  • 6. Radionuclide imaging in thyroid cancer.
    Clarke SE.
    Nucl Med Commun; 1988 Feb; 9(2):79-82. PubMed ID: 2838774
    [No Abstract] [Full Text] [Related]

  • 7. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK, Fataar A, Byrne MJ, Levitt NS, Matley PJ.
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [Abstract] [Full Text] [Related]

  • 8. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE, Murray T, Connell JM, McLellan AR, Reed NS.
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract] [Full Text] [Related]

  • 9. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
    Hoefnagel CA, Delprat CC, Zanin D, van der Schoot JB.
    Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
    [Abstract] [Full Text] [Related]

  • 10. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P, Unterspann S, Schwähn D, Stoll I, Reincke R.
    Radiobiol Radiother (Berl); 1987 Mar; 28(5):642-4. PubMed ID: 2831560
    [No Abstract] [Full Text] [Related]

  • 11. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA, Udelsman R, Shepstone BJ, Dudley NE, Soper ND.
    J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
    [No Abstract] [Full Text] [Related]

  • 12. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
    Guerra U, Pizzocaro C, Terzi A, Giubbini R, Bestagno M.
    J Nucl Med Allied Sci; 1988 Aug; 32(4):242-7. PubMed ID: 2852709
    [No Abstract] [Full Text] [Related]

  • 13. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
    Holub V, Nĕmec J, Neradilová M, Benová M, Blazek T, Dusek M.
    Radiobiol Radiother (Berl); 1987 Aug; 28(5):640-2. PubMed ID: 2831559
    [No Abstract] [Full Text] [Related]

  • 14. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR, Wilf LH.
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
    Patel MC, Patel RB, Ramanathan P, Ramamoorthy N, Krishna BA, Sharma SM.
    Eur J Nucl Med; 1988 May; 13(10):507-10. PubMed ID: 2836203
    [Abstract] [Full Text] [Related]

  • 16. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
    J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
    [No Abstract] [Full Text] [Related]

  • 17. PET imaging of recurrent medullary thyroid cancer.
    Simon GH, Nitzsche EU, Laubenberger JJ, Einert A, Moser E.
    Nuklearmedizin; 1996 Jun; 35(3):102-4. PubMed ID: 8710526
    [Abstract] [Full Text] [Related]

  • 18. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
    Ahuja S, Koppenhagen K, Ernst H.
    Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
    [Abstract] [Full Text] [Related]

  • 19. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
    Clarke SE, Lazarus C, Mistry R, Maisey MN.
    Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
    [Abstract] [Full Text] [Related]

  • 20. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA, Udelsman R, Soper ND, Shepstone BJ, Dudley NE.
    Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.